METHYLNALTREXONE | METHYLNALTREXONE | ATC A08AA62 ATC N07BB04 ATC N02AA56
NERVOUS SYSTEM NARCOTIC ANTAGONISTS OPIATE ANTAGONISTS TREATMENT OF OPIOID-INDUCED CONSTIPATION PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST NOT CROSS BBB (RESTRICTED) | SUBCUTANEOUS ORAL | Cmax 1.10 MICROMOLAR (0.5 MILLIGRAM/KILLOGRAM) VD 71.5 LITER (65 KILOGRAM) PPB 13 PERCENT Cl 6.1 LITER / HOUR (EQN) HT 8 HOUR | DELTA-TYPE OPIOID RECEPTOR KAPPA-TYPE OPIOID RECEPTOR MU-TYPE OPIOID RECEPTOR | Mu-type opioid receptor UNIPROT P35372 OPRM1 -- Kappa-type opioid receptor UNIPROT P41145 OPRK1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |